Abstract
In this study, a newly-synthesized metalloporphyrin, Gd-chlorin (PB Chlorin), was investigated by using a simple tissue phantom to test its efficacy as an MRI contrast, agent. This study demonstrated the potential activity of Gd-chlorin as not only a MRI contrast agent, but also as a PDT photosensitizer by using a simple tissue phantom and conducting a very brief MRI experiment.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Almeida, R. D., Manadas, B. J., Carvalho, A. P., and Duarte, C. B., Intracellular signaling mechanisms in photodynamic therapy.Biochim. Biophys. Acta, 1704, 59–86 (2004).
Chwilkowska, A., Saczko, J., Modrzycka, T., Marcinkowska, A., Malarska, A., Bielewicz, J., Patalas, D., and Banas, T., Uptake of photofrin II, a photosensitizer used in photodynamic therapy, by tumour cellsin vitro.Acta Biochim. Polonica, 50, 509–513 (2003).
Damoiseau, X., Schuitmaker, H. J., Lagerberg, J. W. M., and Hoebeke, M., Increase of the photosensitizing efficiency of the Bacteriochlorin a by liposome-incorporation.J. Photochem. Photobiol. B Biol., 60, 50–60 (2001).
Decreau, R., Richard, M. J., Verrando, P., Chanon, M., and Julliard, M., Photodynamic activities of silicon phthalocyanines against achromic M6 melanoma cells and healthy human melanocytes and keratinocytes.J. Photochem. Photobiol. B Biol., 48, 48–56 (1999).
Ichikawa, K., Takeuchi, Y., Yonezawa, S., Hikita, T., Kurohane, K., Namba, Y., and Oku, N., Antiangiogenic photodynamic therapy (PDT) using Visudyne causes effective suppression of tumor growth.Cancer Lett., 205, 39–48 (2004).
Lee, W. Y., Lim, D. S., Ko, S. H., Park, Y. J., Ryu, K. S., Ahn, M. Y., Kim, Y. R., Lee, D. W., and Cho, C. W., Photoactivation of pheophorbide a induces a mitochondrial-mediated apoptosis in Jurkat leukaemia cells.J. Photochem., Photobiol. B Biol., 75, 119–126 (2004).
Lim, D. S., Ko, S. H., and Lee, W. Y., Silkworm-pheophorbide a mediated photodynamic therapy against B16F10 pigmented melanoma.J. Photochem. Photobiol. B Biol., 74, 1–6 (2004).
Lim, D. S., Ko, S. H., Won, D. H., Lee, C. H., and Lee, W. Y., Photodynamic anti-tumor activity of a new chlorine-based photosensitizer against Lewis Lung Carcinoma cellsin vitro andin vivo.J. Porphyrins Phthalocyanines, 7, 155–161 (2003).
Sharman, W. M., Allen, C. M., and van Lier, J. E., Photodynamic therapeutics: basic principles and clinical applications.Drug Discovery Today, 4, 507–517 (1999).
Smith, K. M., Goff, D. A., and Simpson, D. J., Meso substitution of chlorophyll derivatives: Direct route for transformation of bacteriopheophorbides d into bacteriopheophorbides c.J. Am. Chem. Soc., 107, 4946–4954 (1985).
Sternberg, E. D. and Dolphin, D., Porphyrin-based photosensitizers for Use in Photodynamic Therapy.Tetrahedron, 54, 4151–4202 (1998).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kim, JK., Kim, Dm., Kang, MS. et al. Gadolinium-chlorin is potentially a new tumor specific MRI contrast agent. Arch Pharm Res 29, 188–190 (2006). https://doi.org/10.1007/BF02969390
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02969390